The First European Cardiovascular Forum will provide a unique opportunity for European
experts to discuss optimal management across the complete cardiovascular disease
spectrum. This meeting, led by scientists at the forefront of cardiovascular disease,
will enable in-depth discussions among all attendees on a range of topics crucial
to effective cardiovascular disease management.
|
FRIDAY 5 MAY 2006
|
|
Timing
|
Proposed topic
|
Discussion points
|
|
12.00-13.30
|
Welcome Buffet
|
|
13.30-13.40
|
Welcome
G Stergiou (Greece)
|
|
|
13.40-13.50
|
Welcome from Session
Co-chairs
L Ruilope (Spain)
M Weir (USA)
|
|
|
13.50-14.20
|
Evolving Therapeutics of CV Risk Management
TF Lüscher (Switzerland)
|
- Critical milestones in the development/refinement of BP lowering
- Changing treatment goals, including focus on BP as a CV risk factor and importance
of BP lowering
- Discussion of multifaceted approach to successful CV protection
|
|
14.20-15.20
|
Meeting the Challenge of Successful CV Treatment
R. Schmieder (Germany)
R Heine (Netherlands)
|
- Overview of CV risk epidemiology
- Current perceptions of CV treatment success
- Key factors to consider in CV treatment success
|
|
15.20-15.50
|
Coffee Break
|
|
15.50-15.55
|
Welcome from Session
Co-chairs
L Ruilope (Spain)
M Weir (USA)
|
|
|
15.55-16.25
|
CV Risk Assessment and Reduction - Future Perspectives
L Ruilope (Spain)
|
- Evolving developments in the evaluation/measurement of CV risk
- Role of surrogate markers as indicators of treatment success
|
|
16.25-16.55
|
CV Risk Assessment and Reduction - Today's Tools and Limits
JM Mallion (France)
|
- Perspectives on achievable CV risk reduction with established and newer therapeutic
options
|
|
16.55-17.25
|
Point-counterpoint
L Ruilope (Spain)
M Weir (USA)
|
Treatment perspectives
- Variance in patient/physician definitions and expectations of CV treatment success
Discussion of optimal use of current tools for CV risk assessment
|
|
17.25-17.55
|
Q&A Session
|
|
|
17.55-18.10
|
Close/summary
|
|
19.00-22.00
|
Reception and Dinner
|
|
SATURDAY 6 MAY 2006
|
|
Timing
|
Proposed topic
|
Discussion points
|
|
08.00-08.30
|
Breakfast
|
|
08.30-08.40
|
Welcome from Session
Co-chairs
L Ruilope (Spain)
M Weir (USA)
|
|
|
08.40-09.10
|
CV Treatment and Successes in the US
M Weir (USA)
|
- To review the current status of CV treatment strategies and successes in the US
- To discuss similarities and differences in CV treatment strategies between the US
and Europe
- To examine future directions in CV risk management strategies
|
|
09.10-09.50
|
What Constitutes CV Treatment Success - the European Perspective
M Brown (UK)
|
- To review CV management strategies and successes in Europe
- To discuss the determinants of, and barriers to, optimal CV risk management and
ways in which these might be targeted
|
|
09.50-10.30
|
European Guidelines: ARBs in post-MI/HF as a case in point
A Maggioni (Italy)
|
- To discuss European guidelines and perspectives on CV risk management
- Using ARBs in post-MI and HF patients as a case study, review how management strategies
and guidelines have evolved
|
|
10.30-11.00
|
Coffee Break
|
|
11.00-11.30
|
Point-counterpoint
JM Mallion (France)
TF Luscher (Switzerland)
|
Guideline Dissection
- Guidelines and the direction they provide to achieve target BP control
- Representation of patients with increased CV risk in current guidelines
- Guideline target BPs - an evolving story
- Synergy between guidelines and clinical treatment practices/strategies
|
|
11.30-12.15
|
A Futuristic View of Developments in the Prevention and Management of CV Disease
A Nathwani
|
- Review ongoing and prospective research initiatives
- Discuss the potential role of new agents across the CV continuum
|
|
12.15-12.45
|
Q&A Session
|
|
|
12.45-13.00
|
Close/summary
|
|
13.00-14.30
|
Lunch
|
|
14.30-16.00
|
Breakout Session
|
Improving Compliance/persistence - Are We Doing Enough?
- Impact of treatment recommendations on compliance/persistence in different regions
- Tools/practices for maximising compliance/persistence
- Key stakeholders in effective compliance/persistence programmes
|
|
19.00-23.00
|
Reception and Dinner
|